We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Medherant Positions Itself for the next Stage of its Development With the Appointment of a New CEO

Product News   Jun 30, 2019

 
Medherant Positions Itself for the next Stage of its Development With the Appointment of a New CEO

John Burt, CEO

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

InSphero and Yokogawa Enter into Partnership Agreement to Support Drug Development Research

Product News

InSphero AG announced that it has entered into a partnership agreement with Yokogawa Electric Corporation to collaborate on the development of drug discovery and safety.

READ MORE

Lonza Announces Suites for Commercialization of Bioconjugates

Product News

Lonza today announced a collaboration with a global biopharma company. They both aim to commercialize antibody-drug conjugates.

READ MORE

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

Product News

DeepADMET have announced the successful conclusion of a new AI platform, to identify drug targets more efficiently.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE